| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.02B | 20.14B | 20.00B | 18.29B | 16.84B | 15.34B |
| Gross Profit | 5.92B | 7.08B | 7.03B | 6.52B | 6.03B | 5.62B |
| EBITDA | 6.20B | 5.67B | 5.62B | 5.41B | 4.99B | 4.70B |
| Net Income | 1.04B | 993.00M | 841.00M | 1.61B | 1.66B | 1.21B |
Balance Sheet | ||||||
| Total Assets | 42.26B | 58.02B | 56.14B | 54.05B | 47.99B | 43.33B |
| Cash, Cash Equivalents and Short-Term Investments | 1.31B | 869.00M | 864.00M | 974.00M | 723.00M | 848.00M |
| Total Debt | 21.48B | 29.78B | 27.45B | 25.14B | 20.97B | 20.39B |
| Total Liabilities | 29.68B | 41.23B | 38.83B | 36.41B | 31.92B | 30.70B |
| Stockholders Equity | 11.40B | 15.62B | 16.11B | 16.57B | 15.12B | 12.04B |
Cash Flow | ||||||
| Free Cash Flow | 2.18B | 1.46B | 1.29B | 1.16B | -928.00M | 1.75B |
| Operating Cash Flow | 4.39B | 4.85B | 4.50B | 4.81B | 4.39B | 4.57B |
| Investing Cash Flow | -1.93B | -3.70B | -4.75B | -5.41B | -5.47B | -6.17B |
| Financing Cash Flow | -921.38M | -1.14B | 139.00M | 848.00M | 953.00M | 1.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | C$26.77B | 3.85 | 47.62% | 3.94% | 2.75% | 342.54% | |
78 Outperform | C$11.33B | 14.03 | 35.34% | 2.70% | -0.29% | 15.30% | |
75 Outperform | C$11.33B | 13.97 | 34.72% | 2.69% | -0.29% | 15.30% | |
72 Outperform | C$31.99B | 5.17 | 31.28% | 7.42% | 0.11% | 7109.23% | |
62 Neutral | C$29.38B | 24.41 | 7.30% | 9.49% | 2.42% | 24.37% | |
62 Neutral | C$26.77B | 3.99 | 47.85% | 3.89% | 2.75% | 342.54% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |
TELUS has appointed TD Securities and Jefferies as financial advisors to guide the monetisation and partnership strategy for its TELUS Health business, which it describes as a rapidly growing, globally scaled digital health asset with a growing AI-focused product set. The company aims to bring in a strategic partner to enhance TELUS Health’s capabilities, customer reach and financial resources, and views the initiative as a key lever in its broader deleveraging plan, targeting a gradual reduction in net debt to adjusted EBITDA over the next several years and supporting long-term value creation through disciplined capital allocation and a strong free cash flow outlook.
The most recent analyst rating on (TSE:T) stock is a Buy with a C$21.00 price target. To see the full list of analyst forecasts on Telus stock, see the TSE:T Stock Forecast page.
TELUS announced that its leadership, including President and CEO Darren Entwistle and several board members, acquired 357,090 TELUS shares in the open market over November and December, bringing collective insider holdings to about 2.4 million shares. Entwistle has also been taking his entire salary in TELUS shares since 2024 and intends to continue, underscoring management’s alignment with shareholders and confidence in the company’s long-term value.
The company also disclosed it has repurchased and cancelled nearly 2.3 million common shares at an average price of $17.39 as part of a $500 million normal course issuer bid launched in December 2025, a move it says reflects the disconnect between its share price and underlying business fundamentals. TELUS framed the buybacks as complementary to its deleveraging program and phased reduction of its dividend reinvestment plan, citing strong operations and free cash flow growth that support an accelerated path to lower leverage targets through 2027, which could bolster investor confidence and strengthen its financial position in the telecom sector.
The most recent analyst rating on (TSE:T) stock is a Buy with a C$21.00 price target. To see the full list of analyst forecasts on Telus stock, see the TSE:T Stock Forecast page.
TELUS Corporation has announced the full redemption of its C$600 million 3.75% Notes, Series CV, which were due on March 10, 2026. This strategic financial move is set to take place on January 16, 2026, and reflects TELUS’s proactive management of its financial obligations, potentially impacting its financial positioning positively. The redemption aligns with TELUS’s commitment to leveraging its financial strategies to support its operations and maintain its industry standing.
The most recent analyst rating on (TSE:T) stock is a Buy with a C$25.00 price target. To see the full list of analyst forecasts on Telus stock, see the TSE:T Stock Forecast page.
TELUS Corporation announced the pricing terms for its cash tender offers to purchase several series of its outstanding debt securities. The company has set the terms for these offers, which include a mix of reference yields and fixed spreads for different notes. The financing condition for these offers has been satisfied through the company’s recent offerings of Canadian and U.S. junior subordinated notes. The settlement date for the accepted notes is expected on December 16, 2025, after which the purchased notes will be retired and canceled. This move is part of TELUS’s strategy to manage its debt portfolio effectively, potentially impacting its financial flexibility and market positioning.
The most recent analyst rating on (TSE:T) stock is a Hold with a C$19.00 price target. To see the full list of analyst forecasts on Telus stock, see the TSE:T Stock Forecast page.
TELUS Corporation announced an increase in its cash tender offers for seven series of debt securities, raising the Maximum Purchase Amount to accommodate all tendered notes for specific series. The company successfully tendered C$1,873,961,000 in aggregate principal amount of notes, indicating strong participation. This move is likely to impact TELUS’s financial strategy by managing its debt profile, potentially improving its market positioning and financial flexibility.
The most recent analyst rating on (TSE:T) stock is a Hold with a C$19.00 price target. To see the full list of analyst forecasts on Telus stock, see the TSE:T Stock Forecast page.
TELUS has completed the privatization of TELUS Digital, acquiring all outstanding shares for approximately US$539 million, thereby owning 100% of the company. This strategic move is expected to enhance TELUS’s capabilities in AI-powered digital customer experience and SaaS transformation, generating approximately $150 million annually in operational efficiencies. The integration aims to accelerate growth across TELUS’s business lines and create significant shareholder value, positioning the company as a global leader in its industry.
The most recent analyst rating on (TSE:T) stock is a Hold with a C$21.00 price target. To see the full list of analyst forecasts on Telus stock, see the TSE:T Stock Forecast page.